StockNews.com lowered shares of Haemonetics (NYSE:HAE – Free Report) from a strong-buy rating to a buy rating in a research report sent to investors on Friday morning. Several other research analysts also recently issued reports on the stock. Barrington Research dropped their price objective on shares of Haemonetics from $114.00 to $105.00 and set an […]
Haemonetics Co. (NYSE:HAE – Get Free Report) was the target of a large increase in short interest during the month of November. As of November 15th, there was short interest totalling 1,800,000 shares, an increase of 7.1% from the October 31st total of 1,680,000 shares. Based on an average daily trading volume, of 276,000 shares, […]
Great Lakes Advisors LLC increased its position in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 10.1% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 179,863 shares of the medical instruments supplier’s stock after purchasing an additional 16,569 shares during […]
Haemonetics Co. (NYSE:HAE – Get Free Report) saw a large increase in short interest in the month of October. As of October 31st, there was short interest totalling 1,680,000 shares, an increase of 18.3% from the October 15th total of 1,420,000 shares. Currently, 3.4% of the shares of the company are short sold. Based on […]
Haemonetics (NYSE:HAE – Get Free Report) had its price objective hoisted by investment analysts at Citigroup from $90.00 to $94.00 in a report released on Monday, Benzinga reports. The brokerage presently has a “neutral” rating on the medical instruments supplier’s stock. Citigroup’s price objective indicates a potential upside of 5.86% from the company’s previous close. […]